Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Gaut D, Oliai C, Boiarsky J, Zhang S, Salhotra A, Azenkot T, Kennedy VE, Khanna V, Olmedo Gutierrez K, Shukla N, Moskoff B, Park G, Afkhami M, Patel A, Jeyakumar D, Mannis G, Logan AC, Jonas BA, Schiller G

Publication

Leukemia & lymphoma

Publication ID (Profile URL)

https://researcherprofiles.org/profile/436963479

Publication Year

2024

PubMed ID

37801340

Publication Title

Gaut D, Oliai C, Boiarsky J, Zhang S, Salhotra A, Azenkot T, Kennedy VE, Khanna V, Olmedo Gutierrez K, Shukla N, Moskoff B, Park G, Afkhami M, Patel A, Jeyakumar D, Mannis G, Logan AC, Jonas BA, Schiller G. Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Leuk Lymphoma. 2024 Jan; 65(1):69-77.